GlassScriptPhysician profile
Jeffrey R Hischke
NPI 1114902061
$6,258.74
in general payments reported to CMS, 2019-2025
50 companies · $1,405 in 2025
The $1,405 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,101 · 2020: $362 · 2021: $239 · 2022: $748 · 2023: $1,342 · 2024: $1,062 · 2025: $1,405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,808.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,124.50 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $624.05 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Gilead Sciences, INC. | $572.30 | 2019-2025 | |
| Abbott Laboratories | $529.81 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2, Confirm Rx |
| Novo Nordisk INC | $365.07 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $363.06 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $282.82 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Amarin Pharma, INC. | $195.40 | 2019-2023 | |
| Pfizer INC. | $182.47 | 2019-2025 | |
| Antares Pharma, INC. | $173.34 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Astellas Pharma US INC | $154.13 | 2023-2025 | Veozah, Myrbetriq |
| Genentech USA, INC. | $151.01 | 2019-2022 | |
| Amgen INC. | $142.36 | 2019-2025 | Otezla, Repatha, Otezla |
| Merck Sharp & Dohme LLC | $113.79 | 2019-2023 | Steglatro, Belsomra |
| Exact Sciences Corporation | $87.34 | 2023-2024 | Cologuard Collection Kit |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Hischke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.